Michael A Novak, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 611 W Park St, Sc2, Urbana, IL 61801 Phone: 217-383-3130 Fax: 217-383-4451 |
Dr. Jacob A. Stelle, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 611 W. Park St., Ent, Urbana, IL 61801 Phone: 217-383-3130 Fax: 217-383-4451 |
Vicki Prell, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 602 W University Ave, Urbana, IL 61801 Phone: 217-383-3311 |
Muhamad Amine, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 611 W Park St, Ent, Urbana, IL 61801 Phone: 217-383-3130 Fax: 217-383-4451 |
Dr. Ryan G Porter Sr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 611 W. Park St., Sc2, Urbana, IL 61801 Phone: 217-383-3130 Fax: 217-383-4451 |
Charles R Maris, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 602 W. University Avenue, Otolaryngology, Urbana, IL 61801 Phone: 217-383-3130 Fax: 217-383-4451 |
News Archive
Prasco Laboratories announced today that it is now shipping the authorized generic version of ZEGERIDĀ® (omeprazole/sodium bicarbonate) capsules. Authorized generics are generic pharmaceuticals manufactured identically to the brand product and sold under a private label. Under the terms of a distribution and supply agreement with Santarus, Prasco will sell and distribute the capsule form of Omeprazole/Sodium Bicarbonate in 20 mg and 40 mg strengths in the U.S. under the Prasco label.
A new clinical study led by the University of Leicester and conducted in the HOPE clinical trials facility at Leicester's Hospitals has revealed the pivotal role that changing the time of day that a patient receives radiotherapy could play in altering radiotherapy toxicity.
University of Illinois scientists have learned to mask the bitterness of ginseng, a common ingredient of energy drinks.
People with rheumatic diseases don't take their medication on a regular basis, and this leads to poor outcomes in their disease treatment, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
Aquiline Group was retained as ZYTO Corp's (PINKSHEETS: ZYTC) new Investor Relations Firm as of August 10, 2009.
› Verified 1 days ago